2283: Oncimmune Reports Substantial Growth in their Interim Results & Alan Green on 3 Companies

The SharePickers Podcast with Justin Waite - Ein Podcast von Justin Waite

Podimo 90!!! Tage kostenlos! testen

Podimo 90!!! Tage kostenlos! testen

Ein Universum voller exklusiver Podcasts und Hörbücher. Klicken Sie hier um loszulegen!

 Werbung

Kategorien:

Wirtschaft

Oncimmune reports substantial revenue growth achieved with increased commercial activity across the business and Alan Green discusses Synairgen, Destiny Pharma and Mode Global Holdings

Visit the podcast's native language site